StockData
Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc. (RANI) stock

RANINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3039% above fair value
$0.56+0.02 (+3.54%)

Close on Nov 17, 2026Market cap $77.98MP/E –Yield –

Rani Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Rani Therapeutics's total assets was $60.84M at Jun 30, 2026. For fiscal 2025 it was $58.62M, up 60.0% from the year before. The highest annual figure on record is $124.21M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$58.62M+60.0%
FY2024Dec 31, 2024$36.63M-36.7%
FY2023Dec 31, 2023$57.92M-46.4%
FY2022Dec 31, 2022$108.03M-13.0%
FY2021Dec 31, 2021$124.21M+56.4%
FY2020Dec 31, 2020$79.42M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$60.84M+260.1%
Q1 FY2026Mar 31, 2026$51.88M+115.0%
Q4 FY2025Dec 31, 2025$58.62M+60.0%
Q3 FY2025Sep 30, 2025$10.14M-76.7%
Q2 FY2025Jun 30, 2025$16.90M-61.4%
Q1 FY2025Mar 31, 2025$24.13M-54.9%
Q4 FY2024Dec 31, 2024$36.63M-36.7%
Q3 FY2024Sep 30, 2024$43.54M-38.2%
Q2 FY2024Jun 30, 2024$43.73M-47.6%
Q1 FY2024Mar 31, 2024$53.51M-44.5%
Q4 FY2023Dec 31, 2023$57.92M-46.4%
Q3 FY2023Sep 30, 2023$70.44M-34.9%
Q2 FY2023Jun 30, 2023$83.51M-20.0%
Q1 FY2023Mar 31, 2023$96.45M-16.4%
Q4 FY2022Dec 31, 2022$108.03M-13.0%
Q3 FY2022Sep 30, 2022$108.20M-21.0%
Q2 FY2022Jun 30, 2022$104.34M+34.9%
Q1 FY2022Mar 31, 2022$115.31M+45.2%
Q4 FY2021Dec 31, 2021$124.21M–
Q3 FY2021Sep 30, 2021$136.96M–
Q2 FY2021Jun 30, 2021$77.32M–
Q4 FY2020Dec 31, 2020$79.42M–

More Rani Therapeutics figures

See a number that looks wrong?